156 related articles for article (PubMed ID: 34663705)
21. Validation of the Spanish version of DYsphagia in MUltiple Sclerosis questionnaire (DYMUS).
Renom M; Galán I; Vidal X; Aldevert M; Curto G; Feliu P; García I; Gonzalo L; Sibera X; Anglada E; Meza R; García M; Najas V; Mongay-Ochoa N; Arévalo MJ; Vidal-Jordana Á; Tintoré M; Bascuñana H; Montalban X; Terré R; Sastre-Garriga J
Mult Scler Relat Disord; 2023 Jun; 74():104724. PubMed ID: 37086636
[TBL] [Abstract][Full Text] [Related]
22. The prevalence and types of oral- and pharyngeal-stage dysphagia in patients with demyelinating diseases based on subjective assessment by the study subjects.
Milewska M; Grabarczyk K; Dąbrowska-Bender M; Jamróz B; Dziewulska D; Staniszewska A; Panczyk M; Szostak-Węgierek D
Mult Scler Relat Disord; 2020 Jan; 37():101484. PubMed ID: 31704547
[TBL] [Abstract][Full Text] [Related]
23. ENT-MS-12 questionnaire: A novel tool to investigate otolaryngology symptoms in patients with relapsing-remitting multiple sclerosis. Results from a pilot study.
Di Stadio A; Ralli M; Altieri M; Brenner MJ; Dipietro L; Messineo D; Kaski D; Bernitsas E
Mult Scler Relat Disord; 2021 Jan; 47():102660. PubMed ID: 33291034
[TBL] [Abstract][Full Text] [Related]
24. Attitudes of patients with relapsing-remitting form of multiple sclerosis using disease-modifying drugs in Montenegro regarding COVID-19 pandemic.
Radulovic L; Erakovic J; Roganovic M
Mult Scler Relat Disord; 2020 Oct; 45():102380. PubMed ID: 32683304
[TBL] [Abstract][Full Text] [Related]
25. Oropharyngeal dysphagia in patients with multiple sclerosis: do the disease classification scales reflect dysphagia severity?
Fernandes AM; Duprat Ade C; Eckley CA; Silva Ld; Ferreira RB; Tilbery CP
Braz J Otorhinolaryngol; 2013 Aug; 79(4):460-5. PubMed ID: 23929146
[TBL] [Abstract][Full Text] [Related]
26. Mitoxantrone in relapsing-remitting and rapidly progressive multiple sclerosis: Ten-year clinical outcomes post-treatment with mitoxantrone.
Foo EC; Russell M; Lily O; Ford HL
Mult Scler Relat Disord; 2020 Sep; 44():102330. PubMed ID: 32599468
[TBL] [Abstract][Full Text] [Related]
27. Dysphagia in multiple sclerosis.
De Pauw A; Dejaeger E; D'hooghe B; Carton H
Clin Neurol Neurosurg; 2002 Sep; 104(4):345-51. PubMed ID: 12140103
[TBL] [Abstract][Full Text] [Related]
28. Validation of the Persian version of dysphagia in multiple sclerosis questionnaire for the assessment of dysphagia in multiple sclerosis.
Jafari Z; Shahbodaghi MR; Maroufizadeh S; Moghadasi AN
Iran J Neurol; 2018 Jul; 17(3):99-104. PubMed ID: 30886675
[No Abstract] [Full Text] [Related]
29. Management of dysphagia in multiple sclerosis: current best practice.
D'Amico E; Zanghì A; Serra A; Murabito P; Zappia M; Patti F; Cocuzza S
Expert Rev Gastroenterol Hepatol; 2019 Jan; 13(1):47-54. PubMed ID: 30791843
[TBL] [Abstract][Full Text] [Related]
30. Prevalence of dysphagia in a consecutive cohort of subjects with MS using fibre-optic endoscopy.
Solaro C; Cuccaro A; Gamberini G; Patti F; D'Amico E; Bergamaschi R; Berra E; Giusti A; Rezzani C; Messmer Uccelli M; Grasso MG
Neurol Sci; 2020 May; 41(5):1075-1079. PubMed ID: 31863327
[TBL] [Abstract][Full Text] [Related]
31. Validation of the DYALS (dysphagia in amyotrophic lateral sclerosis) questionnaire for the evaluation of dysphagia in ALS patients.
Diamanti L; Borrelli P; Dubbioso R; Capasso M; Morelli C; Lunetta C; Petrucci A; Mora G; Volanti P; Inghilleri M; Tremolizzo L; Mandrioli J; Mazzini L; Vedovello M; Siciliano G; Filosto M; Matà S; Montomoli C;
Neurol Sci; 2022 May; 43(5):3195-3200. PubMed ID: 34853898
[TBL] [Abstract][Full Text] [Related]
32. How effective are disease-modifying drugs in delaying progression in relapsing-onset MS?
Brown MG; Kirby S; Skedgel C; Fisk JD; Murray TJ; Bhan V; Sketris IS
Neurology; 2007 Oct; 69(15):1498-507. PubMed ID: 17699802
[TBL] [Abstract][Full Text] [Related]
33. Electrophysiological Evaluation of Dysphagia in the Mild or Moderate Patients with Multiple Sclerosis: A Concept of Subclinical Dysphagia.
Beckmann Y; Gürgör N; Çakır A; Arıcı Ş; İncesu TK; Seçil Y; Ertekin C
Dysphagia; 2015 Jun; 30(3):296-303. PubMed ID: 25687968
[TBL] [Abstract][Full Text] [Related]
34. The impact of betaplus program on patient treatment satisfaction with interferon beta-1b in multiple sclerosis: Multicentric cross-sectional survey in the western Balkan countries.
Drulovic J; Cukic M; Grgic S; Dincic E; Raicevic R; Nadj C; Toncev G; Vojinovic S; Mesaros S; Kisic Tepavcevic D; Dujmovic I; Tadic D; Miletic-Drakulic S; Dackovic J; Kostic S; Erakovic J; Sakalas L; Savic D; Suknjaja V; Martinovic V; Maric G; Pekmezovic T
Mult Scler Relat Disord; 2017 Jan; 11():56-61. PubMed ID: 28104258
[TBL] [Abstract][Full Text] [Related]
35. Validity and Reliability of the Turkish Version of the Questionnaire for the Assessment of Dysphagia in Multiple Sclerosis.
Tenekeci EG; Kara B; Çetiz A; Demirkaya Ş; Demir N; Açikel C
Noro Psikiyatr Ars; 2018 Sep; 55(3):243-247. PubMed ID: 30224871
[TBL] [Abstract][Full Text] [Related]
36. Methylprednisolone in combination with interferon beta-1a for relapsing-remitting multiple sclerosis (MECOMBIN study): a multicentre, double-blind, randomised, placebo-controlled, parallel-group trial.
Ravnborg M; Sørensen PS; Andersson M; Celius EG; Jongen PJ; Elovaara I; Bartholomé E; Constantinescu CS; Beer K; Garde E; Sperling B
Lancet Neurol; 2010 Jul; 9(7):672-80. PubMed ID: 20542736
[TBL] [Abstract][Full Text] [Related]
37. Modelling disease progression in relapsing-remitting onset multiple sclerosis using multilevel models applied to longitudinal data from two natural history cohorts and one treated cohort.
Tilling K; Lawton M; Robertson N; Tremlett H; Zhu F; Harding K; Oger J; Ben-Shlomo Y
Health Technol Assess; 2016 Oct; 20(81):1-48. PubMed ID: 27817792
[TBL] [Abstract][Full Text] [Related]
38. The frequency of dysphagia and its impact on adults with multiple sclerosis based on patient-reported questionnaires.
Alali D; Ballard K; Bogaardt H
Mult Scler Relat Disord; 2018 Oct; 25():227-231. PubMed ID: 30118877
[TBL] [Abstract][Full Text] [Related]
39. Tongue strength, dysphagia questionnaire, pharyngeal secretions and FEES findings in dysphagia management in amyotrophic lateral sclerosis.
Printza A; Boziki M; Triaridis S; Kiousi V; Arnaoutoglou M; Constantinidis J; Grigoriadis N
Auris Nasus Larynx; 2021 Aug; 48(4):672-682. PubMed ID: 33109427
[TBL] [Abstract][Full Text] [Related]
40. Detection of disability worsening in relapsing-remitting multiple sclerosis patients: a real-world roving Expanded Disability Status Scale reference analysis from the Italian Multiple Sclerosis Register.
Lepore V; Bosetti C; Santucci C; Iaffaldano P; Trojano M; Mosconi P;
Eur J Neurol; 2021 Feb; 28(2):567-578. PubMed ID: 33058344
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
